(TSX:CSU), TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation”) announced today the appointment of Mark Miller to Constellation's Board of Directors. Mr. Miller is the President of Constellation, and Executive Chairman of the Volaris Group. Mr. Miller has worked with Constellation, Volaris Group and its subsidiaries for more than 30 years. […]
(TSX:MDNA),(OTC US:MDNAF),(Other OTC:MDNAF), TORONTO and HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as well as autoimmune and inflammatory diseases is pleased to announce that it will host a live webinar on
Constellation Software Inc. Announces Appointment of Mark Miller to its Board of Directors GlobeNewswire December 09, 2025 TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation”) announced today the appointment of Mark Miller to Constellation's Board of Directors. Mr. Miller is the President of Constellation, and Executive Chairman of the Volaris Group.
Birmingham families who participate will receive the gift of a full table to make this holiday season a little brighter Shipt and the City of Birmingham will be distributing free groceries to 1,000 families on Saturday, December 13, 2025. With the holidays upon us, Shipt aims to make life a little bit easier for the
Medicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data GlobeNewswire December 09, 2025 TORONTO and HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as well as
Calgary, Alberta–(Newsfile Corp. – December 9, 2025) – Haw Capital 2 Corp. (TSXV: HAW.P) (“Haw 2“), further to its press releases dated May 12, 2025, August 8, 2025 and November 21, 2025, is pleased to provide additional information in compliance with Section 11.2 of TSX Venture Exchange (“TSXV“) Policy 2.4 (the “CPC Policy“) regarding the proposed
London, Ontario–(Newsfile Corp. – December 9, 2025) – Abitibi Metals Corp. (CSE: AMQ) (OTCQB: AMQFF) (FSE: FW0) (“Abitibi” or the “Company“) is pleased to announce that, in connection with its previously announced “bought-deal” offering (the “Offering“) led by BMO Capital Markets, as sole bookrunner and lead underwriter (the “Lead Underwriter“), together with Haywood Securities Inc.,
All monetary amounts are expressed in U.S. dollars, unless otherwise indicated. Toronto, Ontario–(Newsfile Corp. – December 9, 2025) – IAMGOLD Corporation (NYSE: IAG) (TSX: IMG) (“IAMGOLD” or the “Company”) is pleased to announce that as of December 9, 2025, the Company has executed on its debt reduction strategy with the repayment of the final $130
Adecoagro S.A. (NYSE: AGRO) (“Adecoagro” or the “Company”) today announced that it has commenced a public offering of $300,000,000 of its common shares, subject to market and other conditions. J.P. Morgan and BofA Securities will act as global coordinators and joint book-running managers. BTG Pactual, Citigroup and Itaú BBA will act as joint book-running managers.
Emeren Group Ltd (“Emeren” or the “Company”) (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced the results of its extraordinary general meeting (“EGM”) of shareholders held on December 9, 2025. Specifically, the Company's EGM of shareholders approved the following: https://mma.prnewswire.com/media/1991546/Emeren_Logo.jpg 1. The adoption and approval of the Agreement and